Livongo Health, Inc. Common Stock
LVGO
LVGO was delisted on the 29th of October, 2020.
291 hedge funds and large institutions have $3.23B invested in Livongo Health, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 173 funds opening new positions, 61 increasing their positions, 45 reducing their positions, and 26 closing their positions.
565% more first-time investments, than exits
New positions opened: 173 | Existing positions closed: 26
199% more capital invested
Capital invested by funds: $1.08B → $3.23B (+$2.15B)
167% more funds holding in top 10
Funds holding in top 10: 6 → 16 (+10)
101% more funds holding
Funds holding: 145 → 291 (+146)
36% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 45
33% more call options, than puts
Call options by funds: $120M | Put options by funds: $90.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$111M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$91.2M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
+$71.9M |
| 4 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$68.1M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$41M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KXA
KPCB XVI Associates
Menlo Park,
California
|
-$209M |
| 2 |
SV
Sapphire Ventures
Austin,
Texas
|
-$172M |
| 3 |
DIG
Dragoneer Investment Group
San Francisco,
California
|
-$116M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$40.4M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$17.8M |
LVGO Hedge Fund Activity: Q2 2020 in Review
291 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Livongo Health, Inc. Common Stock (LVGO) for Q2 2020, worth a combined $3.23B — up 199% from $1.08B a quarter earlier.
Buyers outnumbered sellers: 173 funds opened new LVGO positions and 26 closed out — a net gain of 147 holders — while 61 added to existing stakes and 45 trimmed.
The largest buyer was Vanguard Group, adding an estimated $111M. The largest seller was KPCB XVI Associates, cutting an estimated $209M.
- 291 institutional investors held Livongo Health, Inc. Common Stock (LVGO) as of Q2 2020, up from 145 in Q1 2020.
- Funds reported $3.23B of Livongo Health, Inc. Common Stock stock for Q2 2020, up 199% quarter-over-quarter.
- 173 funds opened new Livongo Health, Inc. Common Stock positions in Q2 2020 and 26 closed out, a net change of +147 holders.
- The largest Livongo Health, Inc. Common Stock buyer in Q2 2020 was Vanguard Group, an estimated $111M added.
- The largest Livongo Health, Inc. Common Stock seller in Q2 2020 was KPCB XVI Associates, an estimated $209M sold.
Based on aggregated 13F filings for Q2 2020.